Fentanyl was developed as a medical drug in 1959 and approved for medical use in 1968.
It was first used in hospital as an injection for severe pain or in anesthetic formulas for surgery. Because of fentanyl’s addictive potential, it is primarily prescribed only for serve pain in end-of-life care, such as with terminal cancer patients.
In the 1990s, the fentanyl patch was approved and, in 1998, fentnayl began being distributed in lozenge form. Following those releases, minor quantities of these forms were diverted from medical facillities, and illegally sold on the street, resulting in a small number of overdose deaths each year.
Overdose deaths
In 2006, a dramatic increase in fentanyl-related overdose deaths began to be recovered in the US. They were tracted to an illicit lab in Toluca, Mexico. When this lab was closed down, the number of deaths dropped back to low levels.
Then, in 2013, deaths started increasing again as labs in Asia manufactured fentanyl in large quantities. Established drug-trafficking organizations began importing fentanyl from these labs, often adding fentanyl to herion, methamphetamine, cocaine and counterfeit prescription drugs. As trafficking patterns expanded, overdose deaths steadily increased again.
The center of disease control and prevention estimates yearsly fentanyl-related deaths at more than 70,000. Over one year, it is estimated that 84 percent of opioid deaths involved a drug from the fentanyl family.